K
v
ire
.com
←
Back
Night
Docs
Library
Review
…
Author
Richard M. Stone
also known as A Peggion, R M Stone, R Stone
Boston University · Boston Medical Center · Harvard University · CancerCare
About this author
Works
1,848
Cited by
76,149
h-index
132
i10
588
ORCID ↗
Top papers
Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia
Brian Druker, François Guilhot, Stephen G. O’Brien, et al.
·
2006
·
New England Journal of Medicine
↗ 3,470
OA
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
Daniel A. Arber, Attilio Orazi, Robert P. Hasserjian, et al.
·
2022
·
Blood
↗ 2,559
OA
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
Richard M. Stone, Sumithra J. Mandrekar, Ben L. Sanford, et al.
·
2017
·
New England Journal of Medicine
↗ 2,166
OA
Randomized Controlled Trial of Azacitidine in Patients With the Myelodysplastic Syndrome: A Study of the Cancer and Leukemia Group B
Lewis R. Silverman, Erin P. Demakos, Bercedis L. Peterson, et al.
·
2002
·
Journal of Clinical Oncology
↗ 1,808
A Tyrosine Kinase Created by Fusion of the <i>PDGFRA</i> and <i>FIP1L1</i> Genes as a Therapeutic Target of Imatinib in Idiopathic Hypereosinophilic Syndrome
Jan Cools, Daniel J. DeAngelo, Jason Gotlib, et al.
·
2003
·
New England Journal of Medicine
↗ 1,694
OA
Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia
Eytan M. Stein, Courtney D. DiNardo, Daniel A. Pollyea, et al.
·
2017
·
Blood
↗ 1,452
OA
Durable Remissions with Ivosidenib in <i>IDH1</i> -Mutated Relapsed or Refractory AML
Courtney D. DiNardo, Eytan M. Stein, Stéphane de Botton, et al.
·
2018
·
New England Journal of Medicine
↗ 1,392
OA
Lenalidomide in the Myelodysplastic Syndrome with Chromosome 5q Deletion
Alan F. List, Gordon W. Dewald, John M. Bennett, et al.
·
2006
·
New England Journal of Medicine
↗ 1,316
Single-Cell RNA-Seq Reveals AML Hierarchies Relevant to Disease Progression and Immunity
Peter van Galen, Volker Hovestadt, Marc H. Wadsworth, et al.
·
2019
·
Cell
↗ 1,169
OA
International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts
Hervé Dombret, John F. Seymour, Aleksandra Butrym, et al.
·
2015
·
Blood
↗ 1,143
OA
Efficacy and Biological Correlates of Response in a Phase II Study of Venetoclax Monotherapy in Patients with Acute Myelogenous Leukemia
Marina Konopleva, Daniel A. Pollyea, Jalaja Potluri, et al.
·
2016
·
Cancer Discovery
↗ 1,048
OA
CPX-351 (cytarabine and daunorubicin) Liposome for Injection Versus Conventional Cytarabine Plus Daunorubicin in Older Patients With Newly Diagnosed Secondary Acute Myeloid Leukemia
Jeffrey E. Lancet, Geoffrey L. Uy, Jörge E. Cortes, et al.
·
2018
·
Journal of Clinical Oncology
↗ 981
OA
Books
Principles of internal medicine
1950
·
McGraw-Hill Book Co
Harrison's Principals of Internal Medicine
1987
·
McGraw-Hill
Harrison's Principles of Internal Medicine: Pretest Self-Assessment and Review (PreTest: Specialty Level)
1994
·
Mcgraw-Hill (Tx)
Harrison's Principles of Internal Medicine (McGraw-Hill International Editions)
2001
·
McGraw-Hill Education (ISE Editions)
Harrison's Principles of Internal Medicine (McGraw-Hill International Editions)
2001
·
McGraw-Hill Education (ISE Editions)